Contact Us

OREM, UT, UNITED STATES, July 21, 2026 /EINPresswire.com/ -- Techcyte, a worldwide leader in AI-powered digital pathology and diagnostics, today announced it has surpassed 11 million AI-assisted scans processed across active customer...

Optiscan Imaging pushes Stage 2 of head and neck cancer live-imaging study ahead of schedule, accelerating clinical validation and potential FDA submissions. Optiscan Imaging (ASX: OIL) has begun Stage 2 of its first-in-human head and neck...

The latest from the Proscia blog: This post is about Concentriq AP and Concentriq LS, which are for Research Use Only, and the research and laboratory workflows they support. It does not describe diagnostic use. Concentriq AP-Dx, Proscia's...